Business Wire Feed

The Biggest Predictor of Business Growth Is Behavior

April 30th, 2026|

New IDEO research reveals a gap in the behaviors that most drive growth: long-term vision, rapid experimentation, and team autonomy—with only 10% of leaders saying their company excels at the combination.SAN FRANCISCO--(BUSINESS WIRE)--IDEO, the global more...

Strand Therapeutics Appoints Kunal Bhatia as Chief Financial Officer

April 29th, 2026|

Veteran biotech investment banker to lead corporate strategy and capital formation as Strand scales programmable mRNA platform and executes its clinical strategyBOSTON--(BUSINESS WIRE)--Strand Therapeutics, a clinical-stage biotechnology company pioneering programmable mRNA medicines, today announced the more...

Prilenia Appoints Dr. Elisabeth Leiderman as Chief Financial Officer

April 28th, 2026|

NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--#ALS--Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and Amyotrophic Lateral Sclerosis (ALS), more...

Affinia Therapeutics to Present AFTX-201 for BAG3-Associated Dilated Cardiomyopathy (DCM) and Highlight Proprietary Capsid Engineering and Manufacturing Data at the American Society of Gene & Cell Therapy 2026 Annual Meeting

April 28th, 2026|

WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that it will present new preclinical more...

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.